First Time Loading...

Akeso Inc
HKEX:9926

Watchlist Manager
Akeso Inc Logo
Akeso Inc
HKEX:9926
Watchlist
Price: 48.45 HKD 2.11%
Updated: Apr 26, 2024

Intrinsic Value

Akeso, Inc. is a clinical-stage biopharmaceutical company, which committed to in-house discovery, development and commercialization of therapies. [ Read More ]

The intrinsic value of one Akeso Inc stock under the Base Case scenario is 42.4 HKD. Compared to the current market price of 48.45 HKD, Akeso Inc is Overvalued by 12%.

Key Points:
Intrinsic Value
Base Case
42.4 HKD
Overvaluation 12%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Akeso Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling Akeso Inc stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Akeso Inc

Provide an overview of the primary business activities
of Akeso Inc.

What unique competitive advantages
does Akeso Inc hold over its rivals?

What risks and challenges
does Akeso Inc face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Akeso Inc.

Provide P/S
for Akeso Inc.

Provide P/E
for Akeso Inc.

Provide P/OCF
for Akeso Inc.

Provide P/FCFE
for Akeso Inc.

Provide P/B
for Akeso Inc.

Provide EV/S
for Akeso Inc.

Provide EV/GP
for Akeso Inc.

Provide EV/EBITDA
for Akeso Inc.

Provide EV/EBIT
for Akeso Inc.

Provide EV/OCF
for Akeso Inc.

Provide EV/FCFF
for Akeso Inc.

Provide EV/IC
for Akeso Inc.

Show me price targets
for Akeso Inc made by professional analysts.

What are the Revenue projections
for Akeso Inc?

How accurate were the past Revenue estimates
for Akeso Inc?

What are the Net Income projections
for Akeso Inc?

How accurate were the past Net Income estimates
for Akeso Inc?

What are the EPS projections
for Akeso Inc?

How accurate were the past EPS estimates
for Akeso Inc?

What are the EBIT projections
for Akeso Inc?

How accurate were the past EBIT estimates
for Akeso Inc?

Compare the revenue forecasts
for Akeso Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Akeso Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Akeso Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Akeso Inc compared to its peers.

Compare the P/E ratios
of Akeso Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Akeso Inc with its peers.

Analyze the financial leverage
of Akeso Inc compared to its main competitors.

Show all profitability ratios
for Akeso Inc.

Provide ROE
for Akeso Inc.

Provide ROA
for Akeso Inc.

Provide ROIC
for Akeso Inc.

Provide ROCE
for Akeso Inc.

Provide Gross Margin
for Akeso Inc.

Provide Operating Margin
for Akeso Inc.

Provide Net Margin
for Akeso Inc.

Provide FCF Margin
for Akeso Inc.

Show all solvency ratios
for Akeso Inc.

Provide D/E Ratio
for Akeso Inc.

Provide D/A Ratio
for Akeso Inc.

Provide Interest Coverage Ratio
for Akeso Inc.

Provide Altman Z-Score Ratio
for Akeso Inc.

Provide Quick Ratio
for Akeso Inc.

Provide Current Ratio
for Akeso Inc.

Provide Cash Ratio
for Akeso Inc.

What is the historical Revenue growth
over the last 5 years for Akeso Inc?

What is the historical Net Income growth
over the last 5 years for Akeso Inc?

What is the current Free Cash Flow
of Akeso Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Akeso Inc.

Financials

Balance Sheet Decomposition
Akeso Inc

Current Assets 5.7B
Cash & Short-Term Investments 2.4B
Receivables 295.6m
Other Current Assets 3B
Non-Current Assets 3.5B
Long-Term Investments 305.5m
PP&E 3.2B
Intangibles 6.4m
Current Liabilities 1.2B
Accounts Payable 354.8m
Other Current Liabilities 849.8m
Non-Current Liabilities 3.3B
Long-Term Debt 2.6B
Other Non-Current Liabilities 698.3m
Efficiency

Earnings Waterfall
Akeso Inc

Revenue
4.5B CNY
Cost of Revenue
-133.2m CNY
Gross Profit
4.4B CNY
Operating Expenses
-2.2B CNY
Operating Income
2.2B CNY
Other Expenses
-188.8m CNY
Net Income
2B CNY

Free Cash Flow Analysis
Akeso Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

Profitability Score
Profitability Due Diligence

Akeso Inc's profitability score is 45/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional ROE
Exceptional ROIC
Exceptional 1-Year Revenue Growth
45/100
Profitability
Score

Akeso Inc's profitability score is 45/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Akeso Inc's solvency score is 85/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Short-Term Solvency
Low D/E
85/100
Solvency
Score

Akeso Inc's solvency score is 85/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Akeso Inc

Wall Street analysts forecast Akeso Inc stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Akeso Inc is 61.55 HKD with a low forecast of 50.5 HKD and a high forecast of 73.5 HKD.

Lowest
Price Target
50.5 HKD
4% Upside
Average
Price Target
61.55 HKD
27% Upside
Highest
Price Target
73.5 HKD
52% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

Price
Akeso Inc

1M 1M
+3%
6M 6M
+25%
1Y 1Y
+16%
3Y 3Y
-11%
5Y 5Y
+99%
10Y 10Y
+99%
Annual Price Range
48.45
52w Low
31.25
52w High
51.95
Price Metrics
Average Annual Return 31.92%
Standard Deviation of Annual Returns 48.27%
Max Drawdown -82%
Shares Statistics
Market Capitalization 40.7B HKD
Shares Outstanding 865 857 024
Percentage of Shares Shorted
N/A

Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Akeso Inc Logo
Akeso Inc

Country

China

Industry

Biotechnology

Market Cap

40.7B HKD

Dividend Yield

0%

Description

Akeso, Inc. is a clinical-stage biopharmaceutical company, which committed to in-house discovery, development and commercialization of therapies. The company is headquartered in Zhongshan, Guangdong. The company went IPO on 2020-04-24. The firm is dedicated to addressing global unmet medical needs in oncology, immunology and other therapeutic areas. The firm's main products include AK104, AK105, AK112 and AK109. The firm conducts its businesses within the China market and to overseas markets.

Contact

GUANGDONG
Zhongshan
No.6 Shennong Road, Huoju Development Zone
+8676089873936.0
http://www.akesobio.com/

IPO

2020-04-24

Employees

1 202

Officers

Founder, CEO, President & Chairwoman
Dr. Yu Xia Ph.D.
Co-Founder, Executive VP, CSO & Executive Director
Dr. Baiyong Li Ph.D.
Co-Founder, Senior VP & Executive Director
Mr. Zhongmin Wang Ph.D.
Senior VP & Executive Director
Mr. Yu Xia Ph.D.
Co-Founder & Senior VP
Dr. Peng Zhang Ph.D.
Senior Vice President
Dr. Jing Min Ph.D.

See Also

Discover More
What is the Intrinsic Value of one Akeso Inc stock?

The intrinsic value of one Akeso Inc stock under the Base Case scenario is 42.4 HKD.

Is Akeso Inc stock undervalued or overvalued?

Compared to the current market price of 48.45 HKD, Akeso Inc is Overvalued by 12%.